Discovery Program Leader (DPL), Nonclinical Drug Safety (NDS) β Immunology/Oncology
Responsibilities
- Represent NDS on discovery teams and participate in therapeutic area discovery governance reviews.
- Define and oversee NDS strategy for programs in all modalities (small molecules, peptides, biologics, ADCs) from Target Identification through First-In-Human enabling GLP toxicity approval.
- Provide target risk assessments, de-risking strategies, and collaborate with NDS staff across sites to execute studies supporting therapeutic target selection and new candidate development.
- May lead early development teams: define GLP toxicology strategy/execution and non-clinical safety sections of regulatory documents supporting clinical trials and marketing authorization.
- Facilitate creative thinking from target ID/validation through lead optimization (primarily Immunology; also Oncology and other therapeutic areas as needed).
- Identify/assess risks using literature, internal data, and external information.
In This Role You Will
- Influence cross-site disease area and functional disciplines; be a βdrug creatorβ promoting innovation.
Qualifications / Skills
- PhD (or equivalent) in Toxicology, Pharmacology, Pathology, Biology, Biochemistry, Immunology, Pharmaceutical Sciences, Chemistry, or related STEM; DVM/MD acceptable.
- 8+ years pharmaceutical industry experience in nonclinical safety (e.g., toxicology/pathology) and/or nonclinical safety assessment across discovery/development.
- Proven cross-functional leadership in a matrix organization; creative problem solving and timely delivery.
- Strong collaboration, interpersonal, and communication skills.